BioWorld - Wednesday, January 31, 2024

Conferences, BioWorld MedTech
Conferences, BioWorld MedTech RSS Feed RSS

Ribbons of digital data
Bio-IT World Conference & Expo Europe

Is AI on the way to designing drugs? Astrazeneca thinks so

Nov. 30, 2023
By Shani Alexander
No Comments
Artificial Intelligence (AI) driven tools have the ability to design new drugs, with a bit of help from humans, said Anders Hogner, from Astrazeneca plc’s R&D department at the Bio-IT World Conference & Expo Europe in London. “We don’t have anything out there yet,” he added, but the company appears to be working on it.
Read More

Surmodics reveals positive data for its Sundance Sirolimus DCB

Nov. 20, 2023
By Shani Alexander
No Comments
Surmodics Inc. reported positive two-year data from the SWING trial, the first-in-human study to look at the safety of its Sundance Sirolimus drug-coated balloon (DCB) when used to treat occlusive disease of the infrapopliteal arteries. Results presented at the VEITHsymposium in New York showed that the Sundance Sirolimus DCB demonstrated an excellent safety profile and achieved primary patency of 71.4% at 24 months in the per protocol analysis population.
Read More
Xeltis Axess vascular access conduit
VEITHsymposium

Xeltis’ vascular Axess graft implant sees no infection after one year

Nov. 17, 2023
By Shani Alexander
No Comments
One-year data from Xeltis AG’s first-in-human Axess vascular conduit trial showed outstanding results in patients with end stage renal disease who were deemed unsuitable for arteriovenous (AV) fistula creation. The results, presented at the VEITHsymposium in New York, showed 100% secondary patency, 78% primary assisted patency and no infections were observed in data from 20 patients implanted with the Axess conduit.
Read More
Dollar sign and Euro symbol in cogwheels
Jefferies London Healthcare Conference

Jeffries says health care M&A activity expected to rise next year

Nov. 14, 2023
By Shani Alexander
No Comments
Senior leaders and investors in the health care sector expect mergers and acquisitions (M&A) activity to continue to pick up next year but this will be corporate led rather than private equity, according to a report by global investment bank Jefferies. At the same time, many executives remained concerned about the lack of funding in the sector as it was identified as the number one threat.
Read More
The_PASCAL_Precision_transcatheter_valve_repair_system
TCT 2023

Edwards’ Pascal reduces mitral regurgitation in 96% of CLASP IID participants

Oct. 27, 2023
By Annette Boyle
No Comments

One-year results from the CLASP IID trial and registry showed outstanding results in patients with significant symptomatic degenerative mitral regurgitation (DMR) for Pascal, Edwards Lifesciences Corp.’s transcatheter-edge-to-edge repair (TEER) system, in a presentation at the 2023 Transcatheter Cardiovascular Therapeutics (TCT) meeting in San Francisco hosted by the Cardiovascular Research Foundation.


Read More
Boston Scientific Corp.’s Watchman Flx device
TCT 2023

With Amulet or Watchman, 50% of patients still leak either way

Oct. 26, 2023
By Annette Boyle
No Comments
Left atrial appendage (LAA) occlusion procedures are designed to reduce the risk of thromboembolism in patients who have non-valvular atrial fibrillation, but a study presented at the 2023 Transcatheter Cardiovascular Therapeutics annual meeting in San Francisco demonstrated that about half of patients continue to have LAA leaks – and potentially the risk of dangerous blood clots and stroke – a year after the procedure.
Read More